Mast cell function: regulation of degranulation by serine/threonine phosphatases
- PMID: 16790278
- DOI: 10.1016/j.pharmthera.2006.04.011
Mast cell function: regulation of degranulation by serine/threonine phosphatases
Abstract
Mast cells play both effector and modulatory roles in a range of allergic and immune responses. The principal function of these cells is the release of inflammatory mediators from mast cells by degranulation, which involves a complex interplay of signalling molecules. Understanding the molecular architecture underlying mast cell signalling has attracted renewed interest as the capacity for therapeutic intervention through controlling mast cell degranulation is now accepted as a viable proposition. The dynamic regulation of signalling by protein phosphorylation is a well-established phenomenon and many of the early events involved in mast cell activation are well understood. Less well understood however are the events further downstream of receptor activation that allow movement of granules through the cytoskeletal barrier and docking and fusion of granules with the plasma membrane. Whilst a potential role for the protein phosphatase family of signalling enzymes in mast cell function has been accepted for some time, the evidence has largely been derived from the use of broad specificity pharmacological inhibitors and results often depend upon the experimental conditions, leading to conflicting views. In this review, we present and discuss the pharmacological and recent molecular evidence that protein phosphatases, and in particular the protein phosphatase serine/threonine phosphatase type 2A (PP2A), have major regulatory roles to play and may be potential targets for the design of new therapeutic agents.
Similar articles
-
Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation.Cell Signal. 2010 Dec;22(12):1882-90. doi: 10.1016/j.cellsig.2010.07.017. Epub 2010 Aug 2. Cell Signal. 2010. PMID: 20688157
-
The role of serine/threonine protein phosphatases in exocytosis.Biochem J. 2003 Aug 1;373(Pt 3):641-59. doi: 10.1042/BJ20030484. Biochem J. 2003. PMID: 12749763 Free PMC article. Review.
-
The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system.Int Immunopharmacol. 2005 Sep;5(10):1507-18. doi: 10.1016/j.intimp.2005.05.007. Int Immunopharmacol. 2005. PMID: 16023602 Review.
-
Proteomic analysis of IgE-mediated secretion by LAD2 mast cells.J Proteome Res. 2009 Aug;8(8):4116-25. doi: 10.1021/pr900108w. J Proteome Res. 2009. PMID: 19480418
-
Renaissance of the effector role of the mast cell in bronchial asthma.Ann Ital Med Int. 1995 Apr-Jun;10(2):126-33. Ann Ital Med Int. 1995. PMID: 7619653 Review.
Cited by
-
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.Anticancer Drugs. 2016 Jul;27(6):560-8. doi: 10.1097/CAD.0000000000000358. Anticancer Drugs. 2016. PMID: 26967515 Free PMC article.
-
Quantitative time-resolved phosphoproteomic analysis of mast cell signaling.J Immunol. 2007 Nov 1;179(9):5864-76. doi: 10.4049/jimmunol.179.9.5864. J Immunol. 2007. PMID: 17947660 Free PMC article.
-
Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma.Biomolecules. 2020 Feb 18;10(2):326. doi: 10.3390/biom10020326. Biomolecules. 2020. PMID: 32085629 Free PMC article.
-
Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma.PLoS One. 2011;6(12):e27627. doi: 10.1371/journal.pone.0027627. Epub 2011 Dec 19. PLoS One. 2011. PMID: 22205926 Free PMC article.
-
1-Iodohexadecane Alleviates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in Mice: Possible Involvements of the Skin Barrier and Mast Cell SNARE Proteins.Molecules. 2022 Feb 25;27(5):1560. doi: 10.3390/molecules27051560. Molecules. 2022. PMID: 35268661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources